Evaluation of adverse events noted in children receiving continuous infusions of dexmedetomidine in the intensive care unit.

@article{Honey2010EvaluationOA,
  title={Evaluation of adverse events noted in children receiving continuous infusions of dexmedetomidine in the intensive care unit.},
  author={Brooke Lynn Honey and Donald L. Harrison and Andrew K. Gormley and Peter N. Johnson},
  journal={The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG},
  year={2010},
  volume={15 1},
  pages={30-7}
}
OBJECTIVES Dexmedetomidine is an α(2)-adrenergic receptor agonist with sedative and analgesic effects in mechanically ventilated adults and children. Safety and efficacy data are limited in children. The purpose of this study is to retrospectively identify the incidence and types of adverse events noted in children receiving continuous infusions of dexmedetomidine and evaluate potential risk factors for adverse events. METHODS Between July 1, 2006, and July 31, 2007, data were collected on… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Similar Papers

Loading similar papers…